Evaluation of Clinical and Pathological Characteristics and Routine Treatment of Patients With Prostate Cancer
NCT05690399 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2023-01-19
Summary
To evaluate clinical and pathological characteristics and treatment protocol and outcomes of patients with prostate cancer in 2 centers of Asyut from 2013 to 2023
Conditions
Interventions
- RADIATION
-
Radiotherapy
Effect of radiotherapy on patients
Sponsors & Collaborators
-
Assiut University
lead OTHER
Principal Investigators
-
Assiut University · Assiut University
Eligibility
- Min Age
- 40 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-01-31
- Primary Completion
- 2024-03-31
- Completion
- 2024-04-30
More Related Trials
-
Molecular PET/MR Imaging in Vivo Validation of Biomarker for Human Prostate Cancer
NCT03451812 ·Status: UNKNOWN
-
Prostate Cancer Screening With Abbreviated MRI Protocol
NCT05603351 ·Status: RECRUITING ·Phase: NA
-
ASCVD Management Using CCTA in Prostate Cancer Patients on ADT
NCT05879913 ·Status: RECRUITING ·Phase: NA
-
Evaluation of Targeted Prostate Biopsies Under MRI: Tolerance and Contribution in the Therapeutic Decision - Exploratory Study
NCT05612204 ·Status: RECRUITING ·Phase: NA
-
Imaging Studies to Check the Local Response of Prostate Cancer to Radiation Therapy
NCT01834001 ·Status: RECRUITING
-
Comparing Hypofractionated Radiotherapy Boost to Conventionally Fractionated
NCT02300389 ·Status: COMPLETED ·Phase: NA
-
Alpha Radiation Emitters Device (DaRT) for the Treatment of Locally Recurrent Prostate Cancer
NCT07290998 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Development of Clinical Assessment Technique Using Multi-radiotracer PET/MR in Prostate Cancer
NCT01938339 ·Status: UNKNOWN ·Phase: NA
-
Conformal Radiotherapy (CRT) Alone Versus CRT Combined With HDR BT or Stereotactic Body Radiotherapy for Prostate Cancer
NCT01839994 ·Status: UNKNOWN ·Phase: PHASE3
-
Validity, Reliability and Minimum Detectable Changes of 2-Minute Walk , Timed Up and Go, Sit and Stand Test in Patients With Prostate Cancer
NCT05195190 ·Status: COMPLETED
-
ERG Protein Expression in Prostatic Adenocarcinoma and Its Clinicopathological Features
NCT04825691 ·Status: UNKNOWN
-
A Registry of Participants With Prostate Cancer in Asia
NCT02546908 ·Status: COMPLETED
-
Molecular Imaging Informed Radiation Dose Escalation to Sites of Recurrent Disease and De-escalation to Uninvolved Areas in Salvage Radiotherapy for Prostate Cancer
NCT05328505 ·Status: RECRUITING ·Phase: NA
-
Hypofractionated Adaptive Image-Guided Radiation Therapy for Localized Adenocarcinoma of the Prostate
NCT00809991 ·Status: COMPLETED ·Phase: PHASE2
-
Radiotherapy vs Observation for CRPC
NCT01590498 ·Status: UNKNOWN
-
Stereotactic Body Radiotherapy for Stage I-III Prostate Cancer
NCT02334579 ·Status: UNKNOWN ·Phase: NA
-
PSMA PET/CT for Biochemical Recurrence Detection in Patients With Prostate Cancer
NCT04983459 ·Status: COMPLETED
-
99mTc-P137 SPECT/CT in Prostate Cancer
NCT05672485 ·Status: RECRUITING ·Phase: NA
-
Influence of Prostate Cancer Radiation on Aging
NCT04321187 ·Status: COMPLETED
-
Collection and Measurement of Biomarkers in Prostate Cancer Radiotherapy Patients
NCT02997709 ·Status: RECRUITING
-
Metastasis-directed Therapy in Oligoprogressive Castration-refractory Prostate Cancer
NCT06585007 ·Status: RECRUITING ·Phase: PHASE3
-
Effectiveness of Localized Prostate Cancer Treatments
NCT01492751 ·Status: ACTIVE_NOT_RECRUITING
-
Medical and Economic Evaluation for Intermediate-risk Prostate Cancer
NCT02271659 ·Status: UNKNOWN ·Phase: NA
-
Multicentric Evaluation of the True Negative Predictive Value of Multiparametric MRI for the Detection of Prostate Cancer Using Cystoprostatectomy Specimen as Reference
NCT03960112 ·Status: UNKNOWN ·Phase: NA
-
Study of 225Ac-PSMA-617 in Men With PSMA-positive Prostate Cancer
NCT04597411 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1